New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review

Intern Med. 2024 May 15;63(10):1491-1498. doi: 10.2169/internalmedicine.3211-23. Epub 2024 Feb 19.

Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory viral disease, and several cases of autoimmune diseases have been reported after infection. This report presents the case of a 38-year-old Japanese woman who developed systemic lupus erythematosus (SLE) following COVID-19. Clinical manifestations included dermatological complications, joint pain, and positive autoantibodies. The patient met the SLE classification criteria, and renal involvement was observed. Her symptoms improved with immunosuppressive therapy. A literature review identified 10 similar cases, those with lymphopenia and renal involvement. SLE should be considered in patients with persistent nonspecific symptoms after COVID-19 infection, particularly when hematologic and renal involvement are present.

Keywords: autoimmune disease; case report; coronavirus disease 2019; literature review; systemic lupus erythematosus.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • COVID-19* / complications
  • COVID-19* / diagnosis
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / diagnosis
  • SARS-CoV-2